Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch

Inflammation

Volumn 25, Issue 6, 2001, Pages 361-372

  Sud, S ^a   Yang, S Y ^a   Evans, C H ^b   Robbins, P D ^c   Wooley, P H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Air pouch; Gene therapy; IL 1Ra; PMMA

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR RECEPTOR; BIOMATERIAL; INTERLEUKIN 1 RECEPTOR; POLY(METHYL METHACRYLATE); RECEPTORS, INTERLEUKIN 1;

ARTICLE; DNA DETERMINATION; DRUG EFFECT; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE THERAPY; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PARTICULATE MATTER; POLYMERASE CHAIN REACTION; PROSTHESIS; RETROVIRUS; ANIMAL; DISEASE MODEL; GENE VECTOR; GENETICS; METHODOLOGY; MOUSE STRAIN; PATHOLOGY; TREATMENT OUTCOME;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

ANIMAL; BIOCOMPATIBLE MATERIALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE THERAPY; GENETIC VECTORS; INFLAMMATION; MICE; MICE, INBRED BALB C; POLYMETHYL METHACRYLATE; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; RETROVIRIDAE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; TREATMENT OUTCOME;

EID: 0035206031     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012898513512     Document Type: Article

References (39)

1. Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty
2. Prosthetic synovitis: Clinical and histologic characteristics
3. Prosthetic synovitis
4. Gene therapy of chronic inflammatory disease
5. Gene transfer by retrovirus vectors occurs only in cells that are actively replacing at the time of infection
6. High gene transfer into primary human tumor explants without cell selection
7. Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy
8. Vaccination with irradiated tumor cells engineered to secret GM-CSF stimulates potent, specific and long lasting anti-tumor immunity
9. Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor alpha cDNA for gene therapy of cancer in humans
10. Mechanism of rejection induced by tumor cell targeted gene transfer of IL-2, IL-4, IL-7, TNF or IFN
11. Interleukin-6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells
12. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy
13. Direct gene delivery to synovium: An evaluation of potential vectors in vitro and in vivo
14. In vivo inflammatory response to polymethyl-methacrylate particulate debris: Effect of size, morphology, and surface area
15. Prolonged inflammatory reactions induced by ceramic powders in the rat air pouch model
16. Inflammatory responses to orthopaedic biomaterials in the murine air pouch
17. A model of cellular responses in aseptic loosening: UHMWPE and PMMA particles provoke different responses in the murine air pouch
18. Prolonged inflammatory reactions induced by artificial ceramics in the rat air pouch model
19. Synergistic inflammatory responses to metallic and polymeric particles in the murine air pouch model of aseptic loosening
20. Pathological studies of total joint replacement
21. The pathology of failed total joint arthroplasty
22. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study
23. Immune responses to adenoviral vectors during gene transfer in the brain
24. Enhancement of inflammatory reactions in a non-immunological air pouch model in rats
25. Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: A potential role in osteolysis
26. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization
27. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice
28. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis
29. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
30. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein
31. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis
32. The interleukin-1 receptor antagonist and its delivery by gene transfer
33. Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats
34. Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis
35. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction
36. Production of interleukin 1 in the joint during the development of antigen-induced arthritis in the rabbit
37. Blocking cytokines with genes
38. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects
39. Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor